ClinicalTrials.Veeva

Menu

Role of 3 Tesla Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) for Diagnosis Bladder Cancer Grade and Stage

M

Mansoura University

Status

Unknown

Conditions

Bladder Cancer
Apparent Diffusion Coefficient
Diagnoses Disease
Magnetic Resonance Imaging

Treatments

Diagnostic Test: Magnetic resonance imaging

Study type

Observational

Funder types

Other

Identifiers

NCT03138837
R/17.02.31

Details and patient eligibility

About

assess diagnostic performance of 3-Tesla DW-MRI in detecting and staging bladder cancer and potential role of the ADC value as a biomarker reflecting histological grade and stage.

Enrollment

385 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Men and women 18 years or older
  • Suspected by the out-patient flexible cystoscopy as Non-muscle invasive bladder cancer.
  • Patient who will undergo radical cystectomy.
  • Patient with history of allergy to iodinated contrast media

Exclusion criteria

  • Refuse to complete study requirements

  • Patient with any of the following:

    1. Any metallic fragment or foreign body
    2. Coronary and peripheral artery stents
    3. Aortic stent graft
    4. Prosthetic heart valves and annuloplasty rings
    5. Cardiac pacemaker
    6. Implanted cardioverter-defibrillator (ICD)
    7. Retained trans venous pacemaker and defibrillator leads
    8. Cochlear, otologic, or other ear implant

Trial contacts and locations

1

Loading...

Central trial contact

Abdelwahab R. Hashem, Msc; Mohammed H. Zahran, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems